McEwen Inc. seeks to acquire Canadian Gold
McEwen Inc. signed a letter of intent to acquire Canadian Gold Corp.
The latter, located in Flin Flon, holds 100 per cent interest in the Tartan Mine — a site near Flin Flon that produced 47,000 ounces of gold in 1987-89.
Canadian Gold Corp. recently expanded its strike length of Tartan from eight kilometres to 29.5 km. It's been exploring the mine since 2023.
The two companies signed the letter of intent July 27. The deal must receive approval from a majority of Canadian Gold shareholders; a special meeting is expected before 2026.
McEwen Inc. has three gold mines in the U.S., Canada and Argentina. It's aiming to make an Argentina copper project one of the world's first regenerative copper mines. Rob McEwen, a mining hall of famer, leads the company.
If approved, Canadian Gold shareholders will receive 0.0225 of a McEwen common share for each they hold.
— Free Press staff
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
an hour ago
- Cision Canada
Avant Technologies and Ainnova Tech Advance Clinical Trial Protocol Following FDA Feedback
LAS VEGAS, July 29, 2025 /CNW/ -- Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging technology company developing healthcare solutions, and its Joint Venture partner, Ainnova Tech, Inc. (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced an update on the Company's clinical trial protocol following a recent pre-submission meeting with the U.S. Food and Drug Administration (FDA). Following its mid-July meeting with the FDA, Ainnova has revised its clinical trial protocol with the FDA's comments in mind. The new protocol will be resubmitted for FDA review to ensure compliance, which will mitigate potential costly errors in the development process for Ainnova's planned trial for its Vision AI platform in the early detection of diabetic retinopathy. Late last week, Ainnova's clinical development team met with Fortrea, the Company's Contract Research Organization, to present the updated protocol document. Upon approval, this protocol will pave the way for the initiation of a new clinical trial aligned with the revised guidelines. "We are committed to meeting the highest regulatory standards, and we're confident that these protocol refinements will strengthen our path toward FDA 510(k) clearance," said Vinicio Vargas, Chief Executive Officer at Ainnova and a member of the Board of Directors of Ai-nova Acquisition Corp. (AAC), the company formed by the partnership between Avant and Ainnova to advance and commercialize Ainnova's technology portfolio. "We anticipate finalizing the clinical trial budget soon, with estimated costs coming more into focus as we refine our protocol and navigate the process." The company remains focused on advancing its innovative Vision AI platform to address the early detection of diabetic retinopathy, with the goal of achieving FDA 510(k) approval to obtain clearance from the FDA to market its Vision AI technology in the U.S. and deliver transformative solutions to the market. AAC has the worldwide licensing rights for Ainnova's technology portfolio. The licensing rights include the U.S., where the FDA regulates drug and medical device development, so the success of Ainnova's clinical trial is paramount to marketing the technology portfolio in the United States. Entering the U.S. market will unlock significant commercial potential, and this early engagement with the FDA ensures AAC can do so with speed, credibility, and a validated product. About Ainnova Tech, Inc. Ainnova is a Nevada-based healthtech startup with headquarters in San Jose, Costa Rica, and Houston, Texas. Founded by an experienced and innovative team that is dedicated to leveraging artificial intelligence for early disease detection. Recognized with multiple global awards and renowned partnerships with hospitals and medical device companies, we proudly introduce Vision AI - our cutting-edge platform designed to prevent blindness and detect the early onset of diabetes. Explore how Ainnova is revolutionizing healthcare through advanced technology and proactive solutions. About Avant Technologies Inc. Avant Technologies Inc. is an emerging technology company developing solutions in healthcare using artificial intelligence and biotechnologies. With a focus on pushing the boundaries of what is possible in AI and biotechnology, Avant serves a diverse range of industries, driving progress and efficiency through state-of-the-art technology. More information about Avant can be found at You can also follow us on social media at: Forward-Looking Statements Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements because of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website ( In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company's ability to raise capital on acceptable terms, if at all, the Company's successful development of its products and the integration into its existing products and the commercial acceptance of the Company's products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date after the date of the press release.
Cision Canada
an hour ago
- Cision Canada
Stay Home Forever Inc. Appoints Dane Clarke as First President and Chief Operating Officer
Industry leader brings culture-driven approach to Ontario-based homecare provider Stay Home Forever Inc. as he steps into the newly created role of President and Chief Operating Officer. TORONTO, July 29, 2025 /CNW/ - Stay Home Forever Inc. ("SHF"), a leading provider of private homecare services across Ontario, today announced the appointment of Dane Clarke as the President and Chief Operating Officer, effective immediately. To support its next phase of growth, SHF has created this new role, appointing Dane to lead operations and strategy while driving immediate impact with a culture-driven mission. Dane brings over 20 years of executive experience in healthcare operations, workforce strategy, and organizational growth. He has held leadership roles at CBI Health Group, Sinai Health Systems, and WSIB, leading initiatives that improved outcomes and expanded service delivery. Dane also played a key role in driving system-level change and navigating crisis response for healthcare organizations, including Ontario Health Teams (OHTs), co-chairing the Home Care Table during the covid-19 pandemic, and a key contributor to various initiatives and stakeholder engagements with Ontario Health. He attended the Ivey School of Business, reinforcing his ability to lead transformational change and cross-sector healthcare initiatives. "We are thrilled to welcome Dane to the SHF family," said Saye Sathiyakumar, CEO of Stay Home Forever Inc. "His proven leadership, deep industry knowledge, and passion for compassionate care align perfectly with our values. Dane's vision and operational expertise will be instrumental as we continue to scale our services and innovate in the homecare sector." "Joining Stay Home Forever is both a professional and personal calling," said Dane. "I look forward to working closely with Saye and the SHF team to strengthen our foundation, expand our services, and meet the growing need for culturally responsive care in Ontario." Dane's appointment reflects Stay Home Forever's identity as a proudly minority-owned company. As a second-generation Canadian, his personal experiences bring critical insight to a sector where much of the workforce shares similar backgrounds. His leadership helps ensure that the voices of underrepresented communities are reflected at every level of care. Stay Home Forever Inc. has earned a reputation for delivering personalized and client-centred care rooted in the belief that everyone deserves to live with dignity, comfort and connection. With Dane's leadership, SHF will continue to expand its tailored services and advance culturally responsive care for families across Ontario. About Stay Home Forever Inc. Founded in 2019, Stay Home Forever Inc. is a leading provider of private homecare services in Ontario. The company offers a comprehensive range of services - including personal care, companionship, nursing, and specialized support - all designed to promote independence and enhance quality of life. SHF is committed to delivering compassionate, reliable, and culturally appropriate care that meets the highest standards of excellence.
Canada News.Net
2 hours ago
- Canada News.Net
Spear AI secures funding to turn sonar data into battlefield intel
SAN FRANCISCO, California: A veteran-led startup that's rethinking how submarines gather intelligence just secured its first round of external funding. Spear AI, founded by former U.S. Navy officers, has raised US$2.3 million to develop AI tools that can make sense of passive acoustic data, sounds collected underwater by submarines and sensor networks. The Washington-based startup aims to help operators distinguish whether that sound is a harmless rain squall, a passing whale, or a potentially hostile vessel, and to pinpoint its location and speed. The early-stage funding comes from Cortical Ventures, an AI-focused venture capital firm, and private equity firm Scare the Bear. CEO Michael Hunter, a former analyst supporting Navy SEALs and Joint Special Operations Command, said the capital will help the company double its 40-person team to support both government and commercial clients. Unlike most AI systems trained on labeled images or text, underwater acoustic data lacks extensive, well-structured datasets. Spear AI is trying to close that gap by building a hardware-and-software platform that organizes such data so AI algorithms can use it. The startup sells sensors that can be attached to buoys or vessels to collect acoustic signals, along with software tools that help sort, label, and prepare the data for analysis. The U.S. Navy recently awarded Spear AI a $6 million contract for its labeling tool, underscoring the demand for more advanced data processing solutions in defense. The long-term goal is to achieve a real-time AI-driven analysis of underwater environments, a critical edge in both military and commercial maritime operations. Hunter co-founded the company in 2021 with John McGunnigle, a former U.S. Navy nuclear submarine commander. The pair bootstrapped Spear AI until now, prioritizing development over early contracts. "We wanted to build the product and actually get it out the door before the contract came in," Hunter said. "The only way you can do that is with private capital."
